Table 2.
SZ |
HC |
|||
---|---|---|---|---|
Left | Right | Left | Right | |
rsGlu/Cre | 1.44 ± 0.15a,b | 1.65 ± 0.21b | 1.59 ± 0.18a | 1.66 ± 0.16 |
FWHM | 0.039 ± 0.006 | 0.045 ± 0.006 | 0.038 ± 0.004 | 0.045 ± 0.008 |
S/N | 20.24 ± 3.21 | 18.41 ± 2.67 | 22.76 ± 2.08 | 20.06 ± 2.54 |
CRLB % | 8 ± 1.87a | 7.53 ± 1.12 | 6.65 ± 0.61a | 6.94 ± 0.75 |
GM | 34.2 ± 6.68 | 32.32 ± 7.1 | 35.14 ± 5.52 | 34.66 ± 5.8 |
WM | 62.53 ± 7.6 | 64.4 ± 7.65 | 62.46 ± 7.1 | 62.42 ± 6.91 |
± indicates SD.
SZ, schizophrenia patients; HC, healthy controls; rsGlu/Cre, resting-state glutamate relative to creatine; FWHM, full-width-at-half-maximum; S/N, signal-to-noise ratio; CRLB, Cramer–Rao lower bound; GM, gray matter proportion in voxel; WM, white matter proportion in voxel.
P < .05 significant difference between SZ and HC.
P < .05 significant difference between the two hemispheres.